Mucopolysaccharidosis Type I in Mexico: Case-Based Review

Mucopolysaccharidosis Type I in Mexico: Case-Based Review

Introduction: Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease present in 1:100,000 newborns. Variants in the IDUA (alpha-L-iduronidase) gene decrease the enzyme activity for glycosaminoglycans metabolism. MPS I patients exhibit clinical manifestations that fall on the Hurler, Hur...

Full description

Bibliographic Details
Main Authors:	Consuelo Cantú-Reyna, Diana Laura Vazquez-Cantu, Héctor Cruz-Camino, Yuriria Arlette Narváez-Díaz, Óscar Flores-Caloca, Óscar González-Llano, Carolina Araiza-Lozano, René Gómez-Gutiérrez
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Children
Subjects:	Mucopolysaccharidosis I Mexico iduronidase
Online Access:	https://www.mdpi.com/2227-9067/10/4/642

Similar Items

Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report
by: Ramesh Tatapudi, et al.
Published: (2011-01-01)

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
by: Christiane S. Hampe, et al.
Published: (2020-08-01)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
by: Luning Sun, et al.
Published: (2011-01-01)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
by: Luning Sun, et al.
Published: (2011-01-01)

Case Report: Mucopolysaccharidosis Type I Treatment With α-L-Iduronidase Replacement Therapy
by: Ying Li, et al.
Published: (2022-04-01)

Long-term reestablishment of alpha-L-iduronidase activity in MPS I fibroblasts after non-viral gene transfer
by: Fabiano de Oliveira Poswar, et al.
Published: (2017-12-01)

Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2020-06-01)

Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy
by: Heather G. Mack, et al.
Published: (2018-03-01)

Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
by: Ngoc Thi Bich Can, et al.
Published: (2021-10-01)

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

Mucopolysaccharidosis Type I in the Russian Federation and Other Republics of the Former Soviet Union: Molecular Genetic Analysis and Epidemiology
by: E. Yu Voskoboeva, et al.
Published: (2022-01-01)

Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease
by: Yu-Hone Hsu, et al.
Published: (2017-06-01)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
by: Thomas J. Langan, et al.
Published: (2020-03-01)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
by: Tatiana Pineda, et al.
Published: (2014-01-01)

Molecular Detection and Identification of Α-L-Iduronidase Gene Mutations in 5 Iranian Families Suspected for Muller Syndrome (Mucopolysaccharidosis I)
by: B Nasr- Esfahani, et al.
Published: (2007-07-01)

Articular Syndrome Characteristics in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2021-12-01)

Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10
by: Lalitha R. Belur, et al.
Published: (2020-09-01)

A Biochemical Platform to Define the Relative Specific Activity of <i>IDUA</i> Variants Identified by Newborn Screening
by: Seok-Ho Yu, et al.
Published: (2020-11-01)

Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature
by: Vincenza Gragnaniello, et al.
Published: (2020-11-01)

Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
by: Roberto Giugliani, et al.
Published: (2018-07-01)

A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I
by: Kiterie M. E. Faller, et al.
Published: (2020-09-01)

Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure
by: de Ru Minke H, et al.
Published: (2012-04-01)

Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome
by: Latifa Chkioua, et al.
Published: (2018-05-01)

A Humoral Immune Response Alters the Distribution of Enzyme Replacement Therapy in Murine Mucopolysaccharidosis Type I
by: Steven Q. Le, et al.
Published: (2018-03-01)

The importance of the otorhinolaryngologic evaluation in mucopolysaccharidosis patients
by: Bicalho, Cibele Gomes, et al.
Published: (2011-07-01)

SURGICAL TREATMENT OF CERVICAL STENOSIS IN PATIENTS WITH MUCOPOLYSACCHARIDOSIS: SYSTEMATIC REVIEW
by: S. V. Kolesov, et al.
Published: (2018-07-01)

Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometry
by: Arin K. Oestreich, et al.
Published: (2015-12-01)

Mucopolysaccharidosis Type I Presenting with Persistent Neonatal Respiratory Distress: A Case Report
by: Ali Alsuheel Asseri, et al.
Published: (2023-04-01)

Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I
by: Sarah C. Hurt, et al.
Published: (2024-03-01)

Audiometric evaluation in individuals with mucopolysaccharidosis
by: Marcela Rosana Maia da Silveira, et al.
Published: (2018-12-01)

Audiologic evaluations of children with mucopolysaccharidosis
by: Çağil Gökdoğan, et al.

Alder-Reilly Anomaly in Patients with Mucopolysaccharidosis VI
by: Taiane Alves Vieira, et al.
Published: (2008-09-01)

Mucopolysaccharidosis: MRI Study
by: J Gordon Millichap
Published: (1992-09-01)

Mucopolysaccharidosis: A rare case from ophthalmology perspective
by: Santosh Singh Patel, et al.
Published: (2025-01-01)

Audiologic Evaluation of Patients with Mucopolysaccharidosis at a Pediatric Hospital
by: Gomes, Ariana Braga, et al.
Published: (2011-04-01)

Advances in the Diagnosis and Treatment for Ocular Complication on Mucopolysaccharidosis
by: SHI Meipan, et al.
Published: (2023-07-01)

The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
by: Alexis David, et al.
Published: (2023-03-01)

CRISPR/Cas9 technology in the modeling of and treatment of mucopolysaccharidosis
by: Mehran Reyhani-Ardabili, et al.
Published: (2024-09-01)

Awake airway endoscopy in mucopolysaccharidosis: a case report
by: Sofia Fernandes, et al.
Published: (2023-07-01)

Hearing Loss in Mucopolysaccharidosis
by: Cibele Gomes Bicalho, et al.
Published: (2021-07-01)